HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
1.220
+0.883 (262.02%)
At close: May 15, 2026, 4:00 PM EDT
1.030
-0.190 (-15.55%)
After-hours: May 15, 2026, 7:59 PM EDT
HCW Biologics Market Cap
HCW Biologics has a market cap or net worth of $8.22 million as of May 15, 2026. Its market cap has decreased by -5.43% in one year.
Market Cap
8.22M
Enterprise Value
13.56M
1-Year Change
-5.43%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since the IPO on July 20, 2021, HCW Biologics's market cap has decreased from $285.20M to $8.22M, a decrease of -97.12%. That is a compound annual growth rate of -52.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 8.22M | 213.31% |
| Dec 31, 2025 | 2.62M | -86.80% |
| Dec 31, 2024 | 19.87M | -54.91% |
| Dec 29, 2023 | 44.07M | -35.84% |
| Dec 30, 2022 | 68.69M | -17.13% |
| Dec 31, 2021 | 82.89M | -70.94% |
| Jul 20, 2021 | 285.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SciSparc | 2.82M |
| Virax Biolabs Group | 2.79M |
| Ensysce Biosciences | 2.57M |
| Oragenics | 2.47M |
| Decoy Therapeutics | 2.40M |
| Bone Biologics | 2.28M |
| Biodexa Pharmaceuticals | 2.28M |
| Artelo Biosciences | 2.20M |